Asthma
Showing NaN - NaN of 183
Multiple Breath Washout, a Clinimetric Dataset
Recruiting
- Cystic Fibrosis
- +5 more
- Multiple breath washout testing
-
London, United KingdomRoyal Brompton Hospital
May 5, 2022
Asthma Trial in Hungary, South Africa, United Kingdom (Tezepelumab)
Recruiting
- Asthma
- Tezepelumab
-
Budapest, Hungary
- +6 more
Mar 18, 2022
Asthma, COPD Trial in London, Manchester (SelK2 (Part 1), Placebo (Part 1), SelK2 (Part 2))
Completed
- Asthma
- Chronic Obstructive Pulmonary Disease
- SelK2 (Part 1)
- +3 more
-
London, United Kingdom
- +1 more
Feb 1, 2022
Asthma, Asthma Attack, Asthma Persistent Trial in London (ReferID)
Recruiting
- Asthma
- +3 more
- ReferID
-
London, United KingdomGuys and St Thomas NHS Foundation Trust
Jan 11, 2022
Asthma, Eczema, Constipation Trial in London (CYPHP Evelina London Model of care, Enhanced Usual Care)
Recruiting
- Asthma
- +2 more
- CYPHP Evelina London Model of care
- Enhanced Usual Care
-
London, United KingdomGuy's and St Thomas' NHS Foundation Trust
Jan 19, 2022
Small Airways Physiology in Diseased and Healthy States
Completed
- Asthma
- +4 more
-
London, United KingdomAirway Disease Section, National Heart and Lung Institute, Imper
Nov 3, 2021
Asthma Trial in London (QVM149, High Dose Dual Therapy (ICS/LABA))
Withdrawn
- Asthma
- QVM149
- High Dose Dual Therapy (ICS/LABA)
-
London, Ontario, CanadaRobarts Research Insitute; The University of Western Ontario; Lo
Nov 29, 2021
Asthma Trial in Worldwide (Experimental: Tezepelumab, Placebo)
Completed
- Asthma
- Experimental: Tezepelumab
- Placebo
-
Dothan, Alabama
- +288 more
Oct 29, 2021
Asthma Trial in Worldwide (Benralizumab (Medi-563), Placebo)
Completed
- Asthma
- Benralizumab (Medi-563)
- Placebo
-
Birmingham, Alabama
- +212 more
Oct 20, 2021
Asthma, COPD Trial in London (Therapeutic Dose 1, Therapeutic Dose 2, Supra-therapeutic Dose)
Completed
- Asthma
- Chronic Obstructive Pulmonary Disease
- Therapeutic Dose 1
- +3 more
-
London, Tooting, United KingdomRichmond Pharmacology Ltd
Oct 15, 2021
Cancer, COPD, Asthma Trial in London (SELF-BREATHE)
Recruiting
- Cancer
- +11 more
- SELF-BREATHE
-
London, United KingdomKing's College Hospital NHS Foundation TRUST
Sep 1, 2021
High Dose Prednisolone Pharmacokinetics in Acute and Chronic
Not yet recruiting
- Thyroid Eye Disease
- +4 more
- No intervention - prednisolone is taken as part if routine clinical care.
-
London, United KingdomImperial College Healthcare NHS Trust
Aug 11, 2021
Asthma Trial in London (Bronchial challenge test)
Recruiting
- Asthma
- Bronchial challenge test
-
London, United KingdomAllergy Day Care Unite, Guy's Hospital
Jul 27, 2021
Asthma Trial in Worldwide (CHF 5993 200/6/12.5 µg, CHF 1535 200/6 µg, CHF 1535 200/6 µg + Tiotropium Respimat 2.5 µg)
Completed
- Asthma
- CHF 5993 200/6/12.5 µg
- +2 more
-
Caba, Argentina
- +243 more
Apr 6, 2021
Asthma Trial in Worldwide (CHF 5259 plus Foster 100/6 µg, Foster 100/6 µg)
Completed
- Asthma
- CHF 5259 plus Foster 100/6 µg
- Foster 100/6 µg
-
Dupnitza, Bulgaria
- +43 more
Apr 6, 2021
Asthma Trial in Germany, United Kingdom (GSK2245035 Nasal Spray Solution, Placebo Nasal Spray Solution)
Completed
- Asthma
- GSK2245035 Nasal Spray Solution
- Placebo Nasal Spray Solution
-
Frankfurt, Hessen, Germany
- +5 more
Feb 26, 2021
Asthma Trial in Worldwide (FF/UMEC/VI (100/31.25/25) mcg, FF/UMEC/VI (100/62.5/25) mcg, FF/UMEC/VI (200/31.25/25) mcg)
Completed
- Asthma
- FF/UMEC/VI (100/31.25/25) mcg
- +10 more
-
Birmingham, Alabama
- +408 more
Feb 26, 2021
Chronic Rhinosinusitis, Aspirin Exacerbated Respiratory Disease, Asthma Trial in London (Low salicylate diet, Normal Diet)
Completed
- Chronic Rhinosinusitis
- +3 more
- Low salicylate diet
- Normal Diet
-
London, Ontario, CanadaSt. Joseph's Health Care
Feb 17, 2021